|
p53 Information
p53 monoclonal antibodies
mouse models
|
HUMAN p53
Due to the large number of monoclonal antibodies which recognized human p53, the table has been seperated in three parts :
Human p53 - amino-terminus
Name |
Epitope Location |
Antigen used for immunization |
Isotype |
Other species recognition |
WB |
IP |
Reference |
Comercial availability |
Bp53-1 |
6-15 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
? |
Bp53-31 |
6-15 |
Human p53 |
IgG3 |
? |
Yes |
Yes |
10, 18 |
? |
Bp53-8 |
6-15 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
? |
Bp53-22 |
6-20 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
? |
Bp53-25 |
6-20 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
? |
Bp53-27 |
6-20 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
? |
DO2 |
10-16 |
Human p53 |
IgG |
? |
Yes |
Yes |
9, 15 |
Yes |
L134 |
11-20 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
11, 12 |
No |
B17 |
16-25 |
Human p53 |
IgG2a |
Yes |
Yes |
Yes |
11, 12 |
No |
X77 |
16-25 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
19 |
No |
X73 |
16-25 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
19 |
No |
X18 |
16-25 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
19 |
No |
Bp53-2 |
16-25 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-2 |
16-25 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-13 |
16-25 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-24 |
16-25 |
Human p53 |
IgG2b |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-28 |
16-25 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
No |
C36 |
16-30 |
Human p53 |
IgG1 |
Yes |
Yes |
Yes |
11, 12 |
No |
H461 |
16-30 |
Human p53 |
IgG1 |
Yes |
Yes |
Yes |
11, 12 |
No |
X87 |
16-30 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
18 |
No |
X44 |
16-30 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
18 |
No |
X61 |
16-30 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
18 |
No |
X91 |
16-30 |
Xenopus p53 |
IgG1 |
Yes |
Yes |
Yes |
18 |
No |
Bp53-14 |
16-30 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
No |
DO7 |
21-25 |
Human p53 |
IgG2b |
? |
Yes |
Yes |
9, 15 |
Yes |
DO1 |
21-25 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
9, 15 |
Yes |
Bp53-4 |
21-25 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
No |
BP53-12 |
20-25 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
Yes |
BP53-11 |
20-25 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
No |
BP53-19 |
20-23 |
Human p53 |
IgG |
Yes |
Yes |
Yes |
10, 18 |
No |
DO13 |
26-35 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
9, 16 |
No |
PAb1801 |
46-55 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
3, 5, 12 |
Yes |
H447 |
46-55 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
11, 12 |
No |
H279 |
46-55 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
11, 12 |
No |
DO14 |
56-65 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
16 |
No |
Bp53-20 |
56-65 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
No |
Only mAbs that have been experimentally tested either by ELISA, immunoprecipitation or western blot are listed on these tables.
From the epitope sequence, it is quite possible that other mAbs react with this species.
TOP OF THE PAGE
Human p53 - central region
Name |
Epitope
Location |
Antigen use for immunization |
Isotype |
Other species recognition |
WB |
IP |
Reference |
Comercial availability |
HO15.4 |
86-95 |
Human p53 |
IgG2a |
No |
Yes |
Yes |
13 |
No |
HO16.4 |
86-95 |
Human p53 |
IgG2a |
No |
Yes |
Yes |
13 |
No |
HP64 |
171-185 |
Human p53 |
IgG1 |
Yes |
Yes |
Yes |
11,12 |
No |
HO3.5 |
181-190 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
13 |
No |
HO31.1 |
181-190 |
Human p53 |
IgG1 |
No |
Yes |
Yes |
13 |
No |
DO11 |
181-190 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
16 |
No |
HO13.1 |
211-220 |
Human p53 |
IgG2b |
Yes |
Yes |
Yes |
12 |
No |
PAb240 |
213-217 |
Murine p53 |
IgG1 |
Yes |
Yes |
Yes |
6,7,8 |
Yes |
DO12 |
256-270 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
16 |
No |
Only mAbs that have been experimentally tested either by ELISA, immunoprecipitation or western blot are listed on these tables.
From the epitope sequence, it is quite possible that other mAbs react with this species.
TOP OF THE PAGE
Human p53 - carboxy-terminus
Name |
Epitope Location |
Antigen used for immunization |
Isotype |
Other species recognition |
WB |
IP |
Reference |
Comercial availability |
HO7.1 |
291-300 |
Human p53 |
IgG2a |
No |
Yes |
Yes |
13 |
No |
HO33.8 |
291-300 |
Human p53 |
IgG2a |
No |
Yes |
Yes |
13 |
No |
HO8.1 |
306-361 |
Human p53 |
IgG1 |
Yes |
Yes |
Yes |
13 |
Yes |
PAb122 |
371-380 |
Mouse p53 |
IgG2b |
Yes |
Yes |
Yes |
1, 4, 15 |
Yes |
PAb421 |
371-380 |
Mouse p53 |
IgG2a |
Yes |
Yes |
Yes |
2, 4, 15 |
Yes |
HR231 |
371-380 |
Human p53 |
IgG2b |
Yes |
Yes |
Yes |
10, 11 |
No |
Bp53-3 |
371-380 |
Human p53 |
IgG2a |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-30 |
371-380 |
Human p53 |
IgG2b |
? |
Yes |
Yes |
10, 18 |
No |
Bp53-6 |
376-380 |
Human p53 |
IgG1 |
? |
Yes |
Yes |
10, 18 |
No |
ICA9 |
388-393 |
synthetic peptide |
IgG |
? |
? |
Yes |
14 |
No |
Only mAbs that have been experimentally tested either by ELISA, immunoprecipitation or western blot are listed on these tables.
From the epitope sequence, it is quite possible that other mAbs react with this species.
References
-
1 Gurney EG, Harrison RO and Fenno J (1980) Monoclonal antibodies against simian virus 40 T antigens : evidence for distinct subclasses of large T antigen and for similaraties among nonviral T antigens. J. Virol. 34 : 752-763.
-
2 Harlow E, Crawford LV, Pim DC and Williamson NM (1981) Monoclonal antibodies specific for Simian Virus 40 tumor antigens. J. Virol. 861-869.
-
3 Leppard K and Crawford L (1983) Monoclonal antibodies displaying a novel species specificty for the primate transformation-related protein p53. EMBO J. 2 : 1457-1464.
-
4 Wade-Evans A and Jenkins JR (1985) Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J. 4 : 699-706.
-
5 Banks L, Matlashewski G and Crawford L (1986) Isolation of human-p53 specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159 : 529-534.
-
6 Yewdell JW, Gannon JV and Lane DP (1986) Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59 : 444-452.
-
7 Gannon JV, Greaves R, Iggo R and Lane DP (1990) Activating mutations in p53 produce a common conformational effect - A monoclonal antibody specific for the mutant form. EMBO J. 9 : 1595-1602.
-
8 Stephen CW and Lane DP (1992) Mutant conformation of p53 - precise epitope mapping using a filamentous phage epitope library. J Mol Biol 225 : 577-583.
-
9 Vojtesek B, Bartek J, Midgley CA and Lane DP (1992) An Immunochemical Analysis of the Human Nuclear Phosphoprotein-p53 - New Monoclonal Antibodies and Epitope Mapping Using Recombinant-p53. J Immunol Methods 151 : 237-244.
-
10 Bartek J, Bartkova J, Lukas J, Staskova Z, Vojtesek B and Lane DP (1993) Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 169 : 27-34.
-
11 Legros Y, Lacabanne V, D'Agay MF, Larsen CJ, Pla M and Soussi T (1993) Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells. Bull. du Cancer 80 : 102-110.
-
12 Legros Y, Lafon C and Soussi T (1994) Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein. Oncogene 9 : 2071-2076.
-
13 Legros Y, Meyer A, Ory K and Soussi T (1994) Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein. Oncogene 9 : 3689-3694.
-
14 Hupp TR and Lane DP (1995) Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J Biol Chem 270 : 18165-18174.
-
15 Stephen, C. W., Helminen, P., and Lane, D. P. (1995). Characterisation of epitopes on human p53 using phage-displayed peptide libraries : insights into antibody peptide interactions. J Mol Biol 248, 58-78.
-
16 Vojtesek B, Dolezalova H, Lauerova L, Svitakova M, Havlis P, Kovarik J, Midgley CA and Lane DP (1995) Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene 10 : 389-393.
-
17 Lane DP, Stephen CW, Midgley CA, Sparks A, Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B and Picksley SM (1996) Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12 : 2461-2466.
-
18 Dolezalova H, Vojtesek B and Kovarik J (1997) Epitope analysis of the human p53 tumour suppressor protein. Folia Biol Prague 43 : 49-51.
-
19 Legros and Soussi, Unpublished results
|
|